Macular degeneration is the leading cause of irreversible central vision loss among adults over the age of 50 in the developed world. The condition damages the macula — the small, densely packed region at the centre of the retina responsible for sharp, detailed vision used in reading, driving, and recognizing faces. As age-related macular degeneration (AMD) progresses, central vision deteriorates while peripheral vision typically remains intact, profoundly affecting daily function and independence.
At Doctor Lili Optometry in Vancouver, early detection of macular degeneration is a central priority of every comprehensive eye examination. Because the earliest stages of AMD are often asymptomatic, routine screening is the most effective defence against preventable vision loss.
Age-related macular degeneration (AMD) is a chronic, progressive condition that affects the macula — a structure approximately 5 mm in diameter at the centre of the retina. The macula contains the highest concentration of photoreceptor cells (cones) in the eye and is solely responsible for central, high-resolution vision.
In AMD, metabolic waste products called drusen accumulate beneath the retina, and the supportive tissue layer (retinal pigment epithelium) begins to deteriorate. This process disrupts the nourishment and waste removal that photoreceptor cells depend on, ultimately leading to their death and permanent central vision loss.
AMD is classified as "age-related" because advancing age is the single strongest risk factor. The condition rarely presents before age 50 and increases significantly in prevalence with each subsequent decade of life. It is one of several age-related eye conditions we screen for, alongside cataracts and presbyopia.
AMD takes two forms. The distinction matters because they progress at very different speeds and call for entirely different treatment approaches.
The large majority of all AMD cases. Characterized by the gradual accumulation of drusen — yellow deposits beneath the retina — and progressive thinning of the macular tissue. Dry AMD advances slowly, through three defined stages.
Less common but far more aggressive. Abnormal blood vessels (choroidal neovascularization) grow beneath the retina, leaking fluid and blood into the macular tissue and causing rapid swelling, scarring, and photoreceptor destruction.
Small to medium drusen are present, but vision is typically unaffected. Most patients are unaware of the condition at this stage — it is detected only through a dilated eye examination.
Drusen increase in size and number, and pigmentary changes in the retina may appear. Some patients notice mild blurring or difficulty adapting to low light, though many remain asymptomatic.
Also called geographic atrophy. Significant areas of macular tissue and photoreceptors degenerate, producing a noticeable blind spot or blurred area in central vision and measurable vision loss.
Wet macular degeneration can develop suddenly — patients may notice that straight lines appear wavy or that a dark spot has appeared in their central vision over the course of days to weeks. Without prompt treatment, wet AMD can cause severe and irreversible central vision loss in a matter of months. Critically, wet AMD always develops from a pre-existing dry AMD, which is one reason ongoing monitoring of dry AMD is so important. If you notice a sudden change in your central vision, contact our office right away.
The earliest stages of macular degeneration typically produce no noticeable symptoms, which underscores the importance of regular eye examinations for detection. As the condition advances, patients may experience:
AMD symptoms affect central vision only. Peripheral vision is preserved, which means patients do not go completely blind from AMD alone — but the loss of central vision significantly impairs reading, driving, and most activities requiring detailed visual discrimination. If you notice any of these changes, book a comprehensive eye examination without delay.
Several of these symptoms overlap with other age-related conditions. Difficulty driving after dark, for example, is also a common sign of cataracts. Only a clinical examination can distinguish between them.
Some risk factors are fixed. Others are within your control — and those are where prevention efforts pay off.
Risk increases substantially after age 50 and rises sharply after 70.
Individuals with a first-degree relative with AMD are at significantly elevated risk. Multiple genes involved in complement immune pathways and lipid metabolism have been identified as contributors. While there is a genetic component, AMD is not directly inherited — much like the hereditary pattern seen in glaucoma.
AMD is more prevalent among Caucasian populations, though it affects all racial groups.
The single most significant modifiable risk factor. Smokers are two to four times more likely to develop AMD than non-smokers, and the risk persists for years after cessation.
Hypertension, high cholesterol, and obesity are associated with increased AMD risk and faster progression. Diabetes carries its own retinal risks — see why comprehensive eye exams are essential for diabetics.
Chronic, unprotected sun exposure may contribute to cumulative retinal damage over decades.
Diets low in antioxidants, omega-3 fatty acids, and leafy green vegetables are associated with higher AMD risk. Conversely, nutrient-rich diets have a demonstrated protective effect.
Testing for macular degeneration involves several clinical and imaging techniques performed during a comprehensive eye examination:
After dilating the pupils with eye drops, we use specialized lenses to examine the retina and macula directly. Drusen, pigmentary changes, and signs of wet AMD are visible during this examination.
Non-invasive imaging captures high-resolution cross-sectional scans of the retina, revealing drusen, fluid accumulation, and tissue thinning at a microscopic level. OCT is the gold standard for monitoring AMD.
A square grid of evenly spaced lines with a central fixation dot, administered in-office one eye at a time. It reveals areas where lines appear wavy, broken, blurred, or missing — distortions that can indicate macular change.
High-resolution photographs of the retina document the size and location of drusen and areas of atrophy, providing a baseline for comparison at future visits.
At Doctor Lili Optometry, we incorporate advanced retinal imaging and visual field testing into our comprehensive eye examinations to detect macular changes at the earliest possible stage — often before symptoms appear.
The same examination also screens for other conditions that cause vision loss in this age group, including glaucoma and cataracts. Not sure what to expect? Read what happens before your visit.
Treatment depends entirely on which form of AMD is present and how far it has progressed. Dry AMD is managed to slow progression; wet AMD requires active medical intervention.
The Age-Related Eye Disease Study 2 (AREDS2) established that a specific combination of nutritional supplements — including lutein, zeaxanthin, vitamin C, vitamin E, zinc, and copper — reduces the risk of progression from intermediate to advanced dry AMD by approximately 25%. AREDS2 vitamins are recommended for patients with intermediate AMD, or advanced AMD in one eye. They are not beneficial for early-stage disease or as a general preventive measure.
Supplements formulated to the AREDS2 protocol are widely available. However, patients should consult their optometrist or ophthalmologist before starting supplementation, as the formulation is specific and not all over-the-counter "eye vitamins" match the studied composition.
Smoking cessation, cardiovascular risk management, UV protection, regular exercise, and a diet rich in leafy greens, colourful vegetables, and omega-3 fatty acids all contribute to slowing AMD progression. Many of the same nutrient-dense foods that support eye health apply here.
The primary treatment for wet macular degeneration is intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) medications. These drugs — including ranibizumab (Lucentis), aflibercept (Eylea), and faricimab (Vabysmo) — block the growth signal that drives abnormal blood vessel formation. Injections are administered directly into the eye by a retinal specialist, typically on a monthly or treat-and-extend schedule. Anti-VEGF therapy has been transformative: the majority of treated patients maintain their vision, and a significant proportion experience measurable improvement.
In select cases, a light-activated drug (verteporfin) is injected intravenously and then activated by a low-energy laser directed at the abnormal blood vessels. PDT is used less frequently since the advent of anti-VEGF therapy but remains an option for certain subtypes of wet AMD.
When AMD is suspected or confirmed, Dr. Lili Liang coordinates referrals to retinal specialists for advanced treatment while continuing to provide ongoing monitoring and supportive care at Doctor Lili Optometry. Treatment costs may be partly covered — see our direct billing providers.
While AMD cannot be entirely prevented, substantial evidence supports several strategies for reducing risk and slowing progression:
Eliminating tobacco use is the single most impactful preventive measure available.
Emphasize dark leafy greens (kale, spinach, collard greens), colourful fruits and vegetables, cold-water fish rich in omega-3s, and nuts.
Wear sunglasses that block 100% of UV-A and UV-B rays whenever you are outdoors. Browse UV-protective eyewear in our online shop.
Control blood pressure and cholesterol through diet, exercise, and medical management as appropriate.
Obesity is independently associated with AMD progression.
Annual dilated eye exams after age 50 — or earlier if risk factors are present — enable detection at the earliest, most treatable stages.
Patients already diagnosed with early or intermediate AMD are given a monitoring schedule by their eye care provider. Report any new distortion or change in central vision immediately — do not wait for your next scheduled visit.
Early detection of macular degeneration can mean the difference between preserving functional vision and experiencing preventable vision loss. If you are over 50, have a family history of AMD, or have noticed changes in your central vision, schedule a comprehensive eye examination with Dr. Lili Liang at Doctor Lili Optometry in Vancouver.
Protecting your vision starts with knowing where you stand. See what to expect before your visit.
Book Your Appointment